|
Evaluation of Pharmacotherapy Interventions of Clinical Pharmacists in Intensive Care Unit (ICU)
|
Fatemeh Davoodabadi   , Kaveh Kazemian , Seyed Ali Sobhanian |
| Department of Pharmacoeconomics & Pharmaceutical Management, Faculty of Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran |
|
|
Abstract: (273 Views) |
Background: Patients in the intensive care unit need more investigation and care. The presence of pharmacists for the drug treatment of these patients has received much attention in recent years and the positive effect of their presence has been seen. The aim of this study was to investigate the effect of drug therapy interventions by clinical pharmacists in the intensive care unit.
Methods: This study was conducted in an analytical-cross-sectional and prospective manner in five hospitals in Tehran for 7 months. Patient demographic information was collected and clinical pharmacist interventions and their types were analyzed and categorized. The impact of these interventions on cost reduction was achieved through direct impact on the optimal prescription of drugs and preventing the cost of drug side effects. In the end, the profit of this method was calculated using the difference in cost savings and salary paid to the clinical pharmacist.
Results: A total of 350 interventions were performed on 137 patients and 87 interventions reduced the incidence of drug side effects. The presence of the clinical pharmacist in the intensive care unit economically led to a net benefit of 10-17 billion riyals during this period.
Conclusion: Interventions of clinical pharmacists in the intensive care unit not only help to improve the clinical results of patients, but can also lead to reducing treatment costs and increasing the quality of services provided. Due to the increasing complexity of drug treatments and clinical cases in these areas, it is recommended that clinical pharmacists' educational programs and interventions are seriously considered in these areas in order to benefit from all their potential benefits. |
|
| Keywords: Cost-Benefit Analysis, Critical Care, Drug Therapy, Pharmacists. |
|
|
Full-Text [PDF 785 kb]
(74 Downloads)
|
Letter: Original Article |
Subject:
Special
Received: 2024/10/17 | Accepted: 2025/01/27 | ePublished ahead of print: 2025/02/16 | Published: 2025/03/18
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
